Spots Global Cancer Trial Database for A Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies
Official Title: A Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies
Study ID: NCT00741871
Interventions
Study Description
Brief Summary: This is a Phase 1 dose escalation study to determine the maximum tolerated dose and the dose limiting toxicities of SB1518 when given alone once daily by mouth to subjects with advanced lymphoid malignancies.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
MD Anderson Cancer Center, Houston, Texas, United States
Contact Details
Name: Anas Younes, M.D.
Affiliation: M.D. Anderson Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
